Literature DB >> 26296051

ROD-CONE DYSTROPHY ASSOCIATED WITH WILLIAMS SYNDROME.

Laura Kuehlewein1, SriniVas R Sadda.   

Abstract

PURPOSE: To describe a case of rod-cone dystrophy associated with Williams syndrome.
METHODS: This is an observational case report. The medical history was assessed. Examination included ophthalmoscopy, slit-lamp biomicroscopy, fundus autofluorescence imaging, optical coherence tomography, full-field and multifocal electroretinography, and fluorescence in situ hybridization for genetic testing.
RESULTS: A 14-year-old Asian Indian girl with characteristic facies and heart murmur, and with findings on ophthalmoscopy, slit-lamp biomicroscopy, fundus autofluorescence imaging, optical coherence tomography, full-field electroretinography, and multifocal electroretinography consistent with panretinal rod-cone dystrophy, has been reported. Fluorescence in situ hybridization revealed only 1 copy of the elastin gene on Chromosome 7, confirming the diagnosis of Williams syndrome in this patient.
CONCLUSION: The authors report the first case of a patient with ophthalmic findings characteristic for rod-cone dystrophy in the setting of genetically confirmed Williams-Beuren syndrome.

Entities:  

Mesh:

Year:  2015        PMID: 26296051     DOI: 10.1097/ICB.0000000000000196

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  2 in total

1.  [Efficacy of three-dimensional laparoscopic total thyroidectomy combined with central lymph node dissection for thyroid cancer and its effect on inflammatory responses of the patients].

Authors:  Xue-Wen Liu; Qiang Li; Fei Chen; Zhi-Chao Li; Zong-Hai Huang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-06-20

2.  Two heterozygous mutations identified in one Chinese patient with bilateral macular coloboma.

Authors:  Tao Li; Ying Lin; Hongbin Gao; Chuan Chen; Yi Zhu; Bingqian Liu; Yu Lian; Yonghao Li; Wenli Zhou; Hongye Jiang; Haichun Li; Qingxiu Wu; Xiaoling Liang; Chenjin Jin; Xinhua Huang; Lin Lu
Journal:  Mol Med Rep       Date:  2017-06-29       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.